$0.68
(Market cap
$562 Mln
Revenue (TTM)
$320 Mln
P/E Ratio
--
P/B Ratio
3.3
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
-0.2 %
-
ROCE
-- %
-
Industry P/E
--
-
EV/EBITDA
833.1
-
Debt to Equity
--
-
Book Value
$--
-
EPS
$--
-
Face value
--
-
Shares outstanding
41,332,389
10 Years Aggregate
CFO
$233.64 Mln
EBITDA
$430.11 Mln
Net Profit
$-236.27 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
AngioDynamics (ANGO)
| 11.7 | 7.0 | 29.3 | 55.5 | 17.9 | -11.6 | -1.4 |
|
BSE Sensex*
| -8.3 | 0.7 | 1.0 | -4.0 | 5.5 | 8.2 | 10.7 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
AngioDynamics (ANGO)
| 40.2 | 16.7 | -43.1 | -50.1 | 79.9 | -4.2 | -20.5 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
AngioDynamics (ANGO)
|
14.3 | 561.7 | 320.2 | -36.7 | -11.2 | -20.8 | -- | 3.3 |
| 18.3 | 370.9 | 82.1 | 8.1 | 13.2 | 6.1 | 45.9 | 2.7 |
Shareholding Pattern
View DetailsAbout AngioDynamics (ANGO)
AngioDynamics, Inc., a medical technology company, designs, manufactures, and sells products for the treatment of cardiovascular disease and cancer diagnoses in the United States and internationally. The company operates through Med Tech and Med... Device segments. It offers Auryon Atherectomy system that delivers an optimized wavelength and short pulse width to remove lesions while preserving vessel wall endothelium. The company's thrombus management portfolio includes AlphaVac mechanical thrombectomy system, an emergent mechanical aspiration device that eliminates the need for perfusionist support; thrombolytic catheters that are used to deliver thrombolytic agents, which are drugs to dissolve blood clots in hemodialysis access grafts, arteries, veins, and surgical bypass grafts; and AngioVac venous drainage cannula and extracorporeal circuit for use in extracorporeal circulatory support procedures for periods of up to six hours, as well as with other manufacturers' off-the-shelf pump, filter, and reinfusion cannula facilitate venous drainage. It also offers NanoKnife IRE Ablation System, an alternative to traditional thermal ablation for the surgical ablation of soft tissue; and peripheral products, which include angiographic catheters, guidewires, drainage catheters, and micropuncture kits for use in invasive procedures. In addition, the company provides total abscession drainage catheters for multi-purpose/general and biliary configurations, and nephrostomy options; mini stick MAX Coaxial microintroducer kits and micro-introducer kits; ports; VenaCure EVLT system that are used in endovascular laser procedures to treat superficial venous disease; and Solero Microwave Tissue Ablation System includes solero microwave generator and the solero MW applicators. AngioDynamics, Inc. was founded in 1988 and is headquartered in Latham, New York. Read more
-
CEO, President & Director
Mr. James C. Clemmer
-
CEO, President & Director
Mr. James C. Clemmer
-
Headquarters
Latham, NY
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for AngioDynamics (ANGO)
What is the current share price of AngioDynamics Inc (ANGO) Today?
The share price of AngioDynamics Inc (ANGO) is $14.34 (NASDAQ) as of 28-Jul-2026 16:00 EDT. AngioDynamics Inc (ANGO) has given a return of 17.86% in the last 3 years.
What is the current PB & PE ratio of AngioDynamics Inc (ANGO)?
Since, TTM earnings of AngioDynamics Inc (ANGO) is negative, P/E ratio is not available.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2026
|
--
|
--
|
|
2025
|
--
|
--
|
|
2024
|
--
|
--
|
|
2023
|
--
|
--
|
|
2022
|
--
|
--
|
What is the 52 Week High and Low of AngioDynamics Inc (ANGO)?
The 52-week high and low of AngioDynamics Inc (ANGO) are Rs 15.19 and Rs 8.36 as of 29-Jul-2026.
What is the market cap of AngioDynamics Inc (ANGO)?
AngioDynamics Inc (ANGO) has a market capitalisation of $ 562 Mln as on 24-Jul-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in AngioDynamics Inc (ANGO)?
Before investing in AngioDynamics Inc (ANGO), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.